two named-desired-state-hits
named-desired-state-hits — ucc-research-eval-cppc-nominated-target-outcome
- Tested configuration
- CPPC submitted-method nomination campaign
- Protocol
- CPPC prospective nomination of desired T-cell states
- Dataset
- CPPC B16-OVA mouse melanoma T-cell perturbation screens
- Procedure
- Not reported
- Evaluation
- cppc nominated target outcome
- Coverage
- scored: unreported; eligible: unreported
- Uncertainty
- Not reported
- Evidence
- Author-reported evaluation · source checkedCancer Immunotherapy Data Science Challenge · Abstract; Results Figure 5: Dimt1 and Ndufv2 exceed Screen-1 targets on ICB objective
A source-checked result verifies the numerical transcription, not every model or protocol detail. Evaluation metadata: source checked. Source checked does not mean independently reproduced.
Reproduction
- Split
- source-specific; see protocol and limitations
- Adaptation
- source-specific configuration; see model configuration
- Scoring implementation
- Not reported
No execution recipe has been verified for this exact configuration and evaluation. A benchmark's general instructions may use different inputs, splits or model settings.
Reproducing this published result requires matching its model configuration, data, split and scorer. Source checking or a successful smoke test does not establish score reproduction.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
1 evidence row matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| Reported result two Individual claims | Cancer Immunotherapy Data Science Challenge Abstract; Results Figure 5: Dimt1 and Ndufv2 exceed Screen-1 targets on ICB objective Version: 10.64898/2026.05.21.726863v1; 2026 preprint | source checked automated source review · 2026-09-30T21:43:56Z author reported Audit detailsPrimary-source table transcription and scope review; no independent reproduction or human scientific review. Field: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
View linked audit checks and correction history
Release 2026-09-30-e37e3ab1284d · Record review: source checked
2 source records and release history
- Cancer Immunotherapy Data Science Challenge · Original source · 10.64898/2026.05.21.726863v1; 2026 preprint
- Cancer Immunotherapy Data Science Challenge official code · Original source · 283328a9b8afc6e882eeb503ac4710bbe9f37371
Technical metadata and extraction receipts
Stable ID: ucc-research-result-cppc-nominated-target-outcome-named-desired-state-hits
- metric
- named-desired-state-hits
- metric direction
- higher
- unit
- targets
- printed value
- two
- numeric value
- 2
- source locator
- Abstract; Results Figure 5: Dimt1 and Ndufv2 exceed Screen-1 targets on ICB objective
- uncertainty
- Not reported
- review
- method: automated_source_review; actor: Codex research coverage worker; reviewed at: 2026-09-30T21:43:56Z; note: Primary-source table transcription and scope review; no independent reproduction or human scientific review.
- hit genes
- Dimt1; Ndufv2
- denominator
- Not reported
- claim scope
- desired-state composition endpoint only
Related records
- evaluation: cppc nominated target outcome